Milan Anadkat, MD
Dermatology · Saint Louis, MONPI 1639267149
Payments from drug & device makers
Across 847 payments — averaging $2848.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$573K
- Incyte Corporation$536K
- UCB SA$323K
- AbbVie$298K
- Novartis$189K
- Boehringer Ingelheim$132K
- plus $362K from 15 others
Across 6 payments — averaging $4828.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Onquality Pharmaceuticals (USA) LLC$28K
- Eli Lilly$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 41 | $572,989 |
| Incyte Corporation | 514 | $536,370 |
| UCB SA | 25 | $322,508 |
| AbbVie | 60 | $298,037 |
| Novartis | 25 | $189,492 |
| Boehringer Ingelheim | 39 | $131,897 |
| Janssen Research & Development, LLC | 9 | $101,274 |
| Regeneron | 37 | $76,527 |
| Sanofi US Services Inc. | 13 | $54,579 |
| Boehringer Ingelheim International GmbH | 42 | $38,272 |
| Astrazeneca UK Limited | 2 | $26,562 |
| Biogen | 2 | $26,215 |
| UCB, Inc. | 10 | $18,649 |
| Novocure Inc. | 14 | $11,781 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 6 | $4,676 |
| Boehringer Ingelheim Do Brasil Quimica E Farmaceutical Ltda. | 1 | $2,500 |
| Galderma Laboratories, L.p. | 1 | $237 |
| Boehringer Ingelheim RCV GmbH & Co KG | 1 | $188 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $25 |
| Pfizer | 1 | $15 |
How this compares
$2,412,839 in reported general payments places this provider in the 95th percentile of 263 dermatology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Saint Louis
- Brian KimSaint Louis$2.3M
- Elaine SiegfriedSaint Louis$2.2M
- Craig LeonardiSaint Louis$1.7M
- Amy MusiekSaint Louis$577K
- Ann MartinSaint Louis$512K
- Mary GeorgeSaint Louis$400K
- Duane DilworthSaint Louis$301K
- Jennifer FehlmanSaint Louis$235K
- Dee GlaserSaint Louis$213K
- Emily ColeSaint Louis$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.